CMS Is a Step Closer to Saying How It Will Fix Medicare Drug Payment Cuts for 340B Hospitals

OMB
CMS sent its proposed remedy for illegal Medicare Part B drug payment cuts for 340B hospitals to the White House for clearance to be released.

The U.S. Centers for Medicare & Medicaid Services has sent its proposed remedy for almost five years of illegal Medicare Part B drug payments cuts for 340B hospitals to the White House for clearance to be published in

Read More »

CMS Proposes Rules That Addresses 340B Duplicate Discounts in Medicaid Managed Care

CMS
CMS proposes adding information to Medicaid managed care beneficiaries' insurance cards to facilitate 340B duplicate discount prevention.

The U.S. Centers for Medicare & Medicaid Services wants to make Medicaid managed care organizations use Medicaid-specific codes and group numbers on beneficiary insurance cards to help states, MCOs, and 340B covered entities avoid invoicing manufacturers for prohibited

Read More »

340B Report Publisher and CEO: Is a Contract Pharmacy Breakthrough at Hand?

Breakthrough
Hospital groups' decision to back federal 340B contract pharmacy legislation could be a long-awaited breakthrough, 340B Report Publisher and CEO Ted Slafsky says.

Hospital groups’ decision to support letting Congress end the 340B contract pharmacy standoff could be the breakthrough the field has been waiting for, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Verity Solutions.

Read More »

House GOP Rejects Democrats’ Push to Link 340B Transparency and Contract Pharmacy

E&C 340B
House E&C Democrat Scott Peters (Calif.) spoke in favor of, and fellow Democrat Debbie Dingell (Mich.) spoke against, a Republican bill to impose reporting requirements on 340B DSH hospitals.

Congressional GOP backers of federal reporting requirements for 340B hospitals yesterday rejected Democratic arguments that fairness dictates that those requirements be paired with 340B contract pharmacy requirements for drug manufacturers.

U.S. House Energy & Commerce Committee Republicans, joined

Read More »

Breaking News

House E&C Committee Passes Two Bills That Would Create 340B Entity Reporting Requirements

Energy & Commerce Committee
The House E&C Committee passed a bill to impose reporting requirements on 340B DSH hospitals and potentially other entities. The committee passed another bill that could expose all types of 340B covered entities to separate reporting requirements.

The House Energy & Commerce Committee passed two bills today to impose 340B program reporting requirements on hospitals and other health care providers.

They were among 19 health care, telecommunications, and energy bills that the committee marked

Read More »

House E&C Committee to Vote Tomorrow on Bills That Would Bring Big Changes to 340B

House E&C Committee
The House E&C Committee tomorrow will markup two bills that 340B providers are watching very closely.

340B provider groups won some concessions on controversial Medicaid managed care drug billing language that the full U.S. House Energy & Commerce Committee is marking up tomorrow, lobbyists say. Efforts to get more changes continue.

The committee

Read More »

Health Centers’ Antitrust Case Over 340B Contract Pharmacy Limits Will be Argued July 20

Federal District Court Rochester
There will be a federal district court hearing July 20 in Rochester, N.Y., in two health centers' 340B-related antitrust suit against insulin and diabetes drug makers.

A once-dead lawsuit that accuses drug makers of colluding to deny 340B pricing on insulin and diabetes drugs shipped to contract pharmacies is going to be heard July 20 in federal district court in Rochester, N.Y.

Chief Judge

Read More »

Providers Added Immediately to 340B Under COVID-19 Flexibility Are Not Losing their Eligibility, HRSA Confirms

HRSA OPA homepage
HRSA confirmed that providers granted immediate 340B enrollment under a COVID-19 flexibility are not losing their 340B eligibility and will not need to re-enroll. HRSA recently posted a notice about those enrollments on the OPA homepage.

Federal 340B program officials confirmed last week that providers granted immediate 340B enrollment under a COVID-19 public health emergency flexibility are not losing their 340B eligibility and will not need to re-enroll now that the PHE is over.

Read More »

In “Nasty Surprise,” House Subcommittee Votes to Require Billing Medicaid MCOs at Cost Plus Dispensing Fee for Drugs, Including 340B

Energy & Commerce Health
The U.S. House E&C health subcommittee yesterday unexpectedly passed a bill 27-0 with language that would make it impossible nationally for 340B entities to earn revenue from billing state Medicaid managed care plans above what they pay for 340B-acquired drugs.

340B covered entity representatives are scrambling to respond to a U.S. House subcommittee’s unanimous approval yesterday of a bill that includes language that would make it impossible nationally for entities to earn revenue from billing state Medicaid managed

Read More »

House E&C Full Committee May Vote on 340B Transparency Bill as Soon as Next Week

Pallone
House E&C full committee ranking Democrat Frank Pallone said yesterday that 340B hospital reporting legislation the E&C health subcommittee passed yesterday "may be used to draw an inaccurate narrative about the value of the program.”

The full House Energy & Commerce Committee as of late this morning had not yet said when it will markup 340B hospital reporting legislation that split its health subcommittee in two along party lines yesterday. The committee’s Republican

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer